Translate Bio announced the appointment of George D. Demetri, M.D., a physician-scientist at the Dana-Farber Cancer Institute (DFCI), and a professor of medicine at Harvard Medical School to its Board of Directors. Dr. Demetri is currently the Senior Vice President for Experimental Therapeutics at DFCI, Director of the Sarcoma Center at Dana-Farber/Brigham and Women’s Cancer Center, and Co-Director of the Ludwig Center at Harvard Medical School. His research and clinical interests have centered on mechanism-based drug development for solid tumors, and he has contributed to the development of numerous approved therapies, as well as other new targeted therapeutics in development. Dr. Demetri serves as Chair of the Science Policy and Government Affairs Committee of the American Association for Cancer Research, as well as several scientific and editorial advisory boards.